Dongkook Pharmaceutical Reports 21% Increase in Operating Profit Last Year
[Asia Economy Reporter Ji Yeon-jin] Dongkook Pharmaceutical announced on the 23rd that its cumulative sales based on consolidated financial statements last year amounted to 559.1 billion KRW, an increase of 15.9% compared to the previous year, and operating profit (83.6 billion KRW) and net profit (59.6 billion KRW) increased by 21.9% and 1.0%, respectively.
Hot Picks Today
!["It Has Finally Crossed Borders"... Greater Fear Due to Delayed Detection, No Treatment for Variant Ebola [Reading Science]](https://cwcontent.asiae.co.kr/asiaresize/93/2026052019230771274_1779272587.jpg)
"It Has Finally Crossed Borders"... Greater Fear Due to Delayed Detection, No Treatment for Variant Ebola [Reading Science]
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Sales in the fourth quarter of last year increased by 11.3% year-on-year to 142 billion KRW, while operating profit (10.5 billion KRW) and net profit (20.7 billion KRW) decreased by 38.3% and 1.0%, respectively.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
